Showing 2171-2180 of 2314 results for "".
- Macular Degeneration Conference Series in the Spotlighthttps://modernod.com/news/macular-degeneration-conference-series-in-the-spotlight/2476865/Part of the 2019 Macular Degeneration Association Educational Conference Series will take place on Saturday, September 21, at the Doubletree Chicago North Shore Conference Center Skokie, Illinois. The conference, “Eyes on Sight,” is aimed to deliver the most up-to-date research regarding t
- Wills Eye Hospital Named #1 Ophthalmology Training Program In Americahttps://modernod.com/news/wills-eye-hospital-named-1-ophthalmology-training-program-in-america/2479536/Wills Eye Hospital has taken top honors again this year for the best residency training program in the United States for ophthalmologists. Doximity, which coordinates the vote, is the largest online physician network and is a navigator for medical students conside
- MeiraGTx To Present Clinical Data from Phase 1/2 Trial of AAV-RPE65 at Upcoming Scientific Conferenceshttps://modernod.com/news/meiragtx-to-present-clinical-data-from-phase-1-2-trial-of-aav-rpe65-at-upcoming-scientific-conferences/2476861/MeiraGTx Holdings announced that clinical data updates from the company’s phase 1/2 trial of AAV-RPE65 will be presented at two upcoming medical meetings. The phase 1/2 open-label, multicenter, dose-finding trial evaluated AAV-RPE65 in patients with retinal dystrophy associated with diseas
- MST Innovations Introduces the Scleral IOL Fixation Solutions Packhttps://modernod.com/news/mst-innovations-introduces-the-scleral-iol-fixation-solutions-pack/2476857/MicroSurgical Technology has introduced the Scleral IOL Fixation Solutions Pack, which is designed to streamline the double-needle scleral IOL fixation technique with several unique new instruments that are conveniently packaged to support the procedure end-to-end. The comprehensive offeri
- Staar Surgical Announces Strategic Alliance Agreement with Asian Eye Institutehttps://modernod.com/news/staar-surgical-announces-strategic-alliance-agreement-with-asian-eye-institute/2476850/Staar Surgical Company announced that it has entered a strategic alliance with Asian Eye Institute, an eye care group with nine locations in the Philippines. Asian Eye Institute was founded in 2001 and has 18 medical doctors, two specialist optometrists, and more than 30 staff optometrists on sta
- Oxurion Completes Enrollment of Phase 1 Clinical Trial Evaluating THR-687 for the Treatment of DMEhttps://modernod.com/news/oxurion-completes-enrolment-of-phase-1-clinical-trial-evaluating-thr-687-for-the-treatment-of-dme/2476849/Oxurion NV announced the completion of enrollment of patients in a phase 1 trial with THR-687. The open-label, multicenter, dose escalation phase 1 study is evaluating the safety of a single intravitreal injection of escalating dose levels (3) of THR-687 for the treatment of patients with diabeti
- FDA Approves New Paragon Contact Lens Manufacturing Facility in Phoenixhttps://modernod.com/news/fda-approves-new-paragon-contact-lens-manufacturing-facility-in-phoenix/2476817/The FDA has approved Paragon Vision Science’s newly-constructed contact lens manufacturing site in suburban Phoenix, paving the way for the company’s ongoing domestic and global expansion. The Gilbert, Ariziona facility will produce advanced ortho-k products such as Paragon CRT for use in
- Trump Administration to Appeal Ruling Barring Proposed Drug Price Disclosure Policyhttps://modernod.com/news/trump-administration-to-appeal-ruling-barring-proposed-drug-price-disclosure-policy/2476816/The administration of US President Donald Trump plans to appeal a recent federal court decision striking down a Department of
- Aerie Pharmaceuticals Initiates First-in-Human Clinical Trial of AR-13503 Sustained Release Intravitreal Implant in Patients with Wet AMD and DMEhttps://modernod.com/news/aerie-pharmaceuticals-initiates-first-in-human-clinical-trial-of-ar-13503-sustained-release-intravitreal-implant-in-patients-with-wet-amd-and-dme/2476812/Aerie Pharmaceuticals announced the commencement of patient dosing in a first-in-human clinical trial of AR-13503 Sustained Release (SR) implant in patients with neovascular age-related macular degeneration (AMD) or diabetic macular edema (DME). This multi-arm, 24-week study (AR-13503-CS20
- FDA Approves Eylea Injection Prefilled Syringehttps://modernod.com/news/fda-approves-eylea-injection-prefilled-syringe/2476803/Regeneron Pharmaceuticals announced that the FDA has approved Eylea (aflibercept) Injection prefilled syringe. The 2 mg, single-dose, sterilized prefilled syringe provides physicians with a new way to administer Eylea that requires fewer preparation steps compared to vials. The approval was made